company background image
6669

Acotec Scientific Holdings SEHK:6669 Stock Report

Last Price

HK$8.83

Market Cap

HK$2.8b

7D

1.4%

1Y

n/a

Updated

09 Aug, 2022

Data

Company Financials +
6669 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth5/6
Past Performance0/6
Financial Health4/6
Dividends0/6

6669 Stock Overview

Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally.

Acotec Scientific Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Acotec Scientific Holdings
Historical stock prices
Current Share PriceHK$8.83
52 Week HighHK$19.36
52 Week LowHK$4.21
Beta0
1 Month Change-6.96%
3 Month Change68.51%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-49.83%

Recent News & Updates

Jul 01
An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

An Intrinsic Calculation For Acotec Scientific Holdings Limited (HKG:6669) Suggests It's 49% Undervalued

How far off is Acotec Scientific Holdings Limited ( HKG:6669 ) from its intrinsic value? Using the most recent...

Shareholder Returns

6669HK Medical EquipmentHK Market
7D1.4%3.1%1.5%
1Yn/a-54.1%-22.7%

Return vs Industry: Insufficient data to determine how 6669 performed against the Hong Kong Medical Equipment industry.

Return vs Market: Insufficient data to determine how 6669 performed against the Hong Kong Market.

Price Volatility

Is 6669's price volatile compared to industry and market?
6669 volatility
6669 Average Weekly Movement10.5%
Medical Equipment Industry Average Movement8.7%
Market Average Movement6.6%
10% most volatile stocks in HK Market12.8%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 6669 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: 6669's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
2020400Jing Lihttps://www.acotec.cn

Acotec Scientific Holdings Limited, a medical device company, researches and develops percutaneous transluminal angioplasty and drug-coated balloon products for the treatment of vascular diseases in Mailand China, Europe, and internationally. It offers AcoArt Orchid & Dhalia to prevent stenosis or occlusion in superficial femoral artery and popliteal artery for the treatment of lower extremity artery disease; under clinical studies in nephrology for arteriovenous fistula stenosis and in neurology for vertebral atherosclerotic stenosis indications/applications; and under clinical studies in andrology for vasculogenic erectile dysfunction indications/applications. The company also provides AcoArt Tulip & Litos, which is under registration process in China and Europe, and under preclinical studies in the United States in vascular surgery for below-the-knee artery disease indications/applications; and in pre-clinical studies in andrology for vasculogenic erectile dysfunction indications/applications.

Acotec Scientific Holdings Limited Fundamentals Summary

How do Acotec Scientific Holdings's earnings and revenue compare to its market cap?
6669 fundamental statistics
Market CapCN¥2.38b
Earnings (TTM)-CN¥79.08m
Revenue (TTM)CN¥303.81m

7.8x

P/S Ratio

-30.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6669 income statement (TTM)
RevenueCN¥303.81m
Cost of RevenueCN¥37.87m
Gross ProfitCN¥265.94m
Other ExpensesCN¥345.02m
Earnings-CN¥79.08m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.25
Gross Margin87.53%
Net Profit Margin-26.03%
Debt/Equity Ratio0.5%

How did 6669 perform over the long term?

See historical performance and comparison